NoBlood

Volume 109, Issue 4 , 15 February 2003, Pages 181-188
--------------------------------------------------------------------------------

Copyright © 2003 Elsevier Science Ltd.

Regular Article

Aprotinin restores the adhesive capacity of dysfunctional platelets

John F. Bradfield, and Arthur P. Bode

East Carolina University, School of Medicine, 213 Life Sciences Building, Greenville, NC 27858, USA

Received 20 June 2002; revised 31 January 2003; accepted 3 March 2003. ; Available online 11 April 2003.

Abstract

The post-operative coagulopathy associated with cardiopulmonary bypass (CPB) is known to be predominantly related to platelet dysfunction. The use of the serine protease inhibitor aprotinin dramatically reduces CPB associated hemorrhage and is thought to act primarily through the inhibition of plasmin without directly influencing platelets. Our data indicate that there is a direct effect of aprotinin on platelet adhesion, which has not been previously reported. We found that when aprotinin was added to blood samples with poorly adhesive platelets, platelet adhesion significantly increased as measured by the percent coverage of denuded arterial segments in the Baumgartner perfusion chamber. In preliminary experiments using expired platelet concentrates or fresh whole blood, the addition of aprotinin induced a positive increase of 22±7.5 and 14±6.2 percentage point in platelet adhesion, respectively. A simulated CPB model that recirculated a unit of anticoagulated whole blood for 2 h was used (n=14) to induce a platelet adhesion defect similar to that seen in clinical CPB. At initiation of recirculation, platelet adhesion was 55±9.5% but dropped to 13+6.5% coverage after 2 h simulated CPB. The addition of aprotinin to the post-recirculation samples induced a significant restoration of platelet adhesion back to 38±11% coverage. When epsilon amino-caproic acid with soybean trypsin inhibitor was added to post recirculation samples, there was no similar effect on adhesion scores. To compare these findings with surgical CPB, we collected one blood sample at the beginning and two at the end of CPB from each of seven open-heart patients. Aprotinin was added to one of each of the post-CPB samples. Platelet adhesion at the onset of surgical CPB was only 39±11% in this patient group but dropped to 7±7% by the end. Similar to the model, the addition of aprotinin post-CPB restored adhesion to 29±11%. These results suggest some action of aprotinin other than its antiplasmin effect, and that platelet adhesion in general can be promoted by aprotinin.

Author Keywords: Aprotinin; Platelet adhesion; Cardiopulmonary bypass; Plasmin


Corresponding author. Tel.: +1-252-744-2420; fax: +1-252-744-2355.

__________________
Mr. Jan B. Wade
Blood Management Consultant
Enhance Outcomes - Control Cost
For Information Call - 360 296-1807
Email